INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024

Rhea-AI Summary

INOVIO, a biotechnology company, will release their first quarter 2024 financial results on May 13, 2024. The company focuses on developing DNA medicines for HPV-associated diseases, cancer, and infectious diseases. A live conference call and webcast will follow the release to discuss financial results and give a general business update.

PLYMOUTH MEETING, Pa., April 29, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases, today announced that first quarter 2024 financial results will be released after the market close on May 13, 2024. Following the release, INOVIO will host a live conference call and webcast at 4:30 p.m. ET to discuss financial results and provide a general business update.

The live webcast will be available online at http://ir.inovio.com/events-and-presentations/default.aspx. This is a listen-only event but will include a live Q&A with analysts. The webcast will be archived and available for replay for 90 days following the event.

About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.

Contacts
Media: Jennie Willson (267) 429-8567 jennie.willson@inovio.com
Investors: Thomas Hong (267) 440-4298 thomas.hong@inovio.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-report-first-quarter-2024-financial-results-on-may-13-2024-302129666.html

SOURCE INOVIO Pharmaceuticals, Inc.

FAQ

When will INOVIO report its first quarter 2024 financial results?

INOVIO will release their first quarter 2024 financial results on May 13, 2024.

What is INOVIO focused on developing?

INOVIO is focused on developing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases.

Where can I access the live webcast of the financial results discussion?

The live webcast will be available online at http://ir.inovio.com/events-and-presentations/default.aspx.

Will there be a live Q&A session with analysts during the webcast?

Yes, the webcast will include a live Q&A session with analysts.